magnerot® 500 Injekt

Magnesium is an important mineral with numerous functions in the body.
Since gastrointestinal problems can cause reduced absorption, intravenous administration of magnerot® 500 Injekt is reasonable as it reaches the bloodstream immediately.

  • Therapeutic Indications
    Magnesium deficiency when it causes muscle disorders and oral therapy is not possible.
  • Active Substance and Composition
    1 ampoule (5 ml) contains 500 mg magnesium-D-gluconate (as magnesiumgluconate · X H20 515,46 – 568.18 mg), (= 1.2 mMol = 2.4 mVal = 29.2 mg magnesium).

    Magnesium

    For further substances read the Patient information leaflet.
  • Dosage and Method of Application
    The dosage depends on the severity of the magnesium deficiency.

    For intramuscular (i.m.) and intravenous (i.v.) application (injection). The intramuscular injection has to be applied deep. The intravenous injection has to be applied slowly while the patient is lying (the first 3ml in 3 minutes).

    The injection of one ampoule should be repeated with 1 to 2 days inbetween. A treatment for several weeks is recommended.
  • Package Sizes
    • 10 ampoules à 5 ml Solution for Injection - PZN 2606899
    • 100 ampoules à 5 ml Solution for Injection - PZN 2606899 (10 times)
    • 1000 ampoules à 5 ml Solution for Injection - PZN 2606899 (100 times)
  • Obligatory Text
    magnerot® 500 Injekt. Active substance: magnesium-D-gluconate 500 mg/5 ml solution for injection. Therapeutic indications: Magnesium deficiency when it causes muscle disorders and oral therapy is not possible. If you have any questions about risks and side effects, please read the patient information leaflet and ask your doctor or pharmacist. WÖRWAG Pharma GmbH & Co. KG, 71034 Böblingen
  • Downloads

Related Products